Novartis Advances Cosentyx for Polymyalgia Rheumatica
Basel, Switzerland, September 18, 2026 Novartis has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
European Medicines Agency
Advertisement
AbbVie Submits SKYRIZI SC Induction Application to EMA
North Chicago, Illinois, United States, Aug. 27, 2026 AbbVie has submitted a regulatory application to the European Medicines Agency...
Daiichi Sankyo, AstraZeneca Advance Datroway in Phase 3 Urothelial Cancer Trial
Tokyo, August 26, 2026 Daiichi Sankyo announced that the first patient has been dosed in TROPION-Urothelial04, a global Phase...
INmune Bio Advances Ebstrocel Toward EU Marketing Filing
BOCA RATON, Fla., Aug. 26, 2026 INmune Bio Inc. has advanced Ebstrocel™ toward potential European commercialization after submitting two...
Pfizer and Valneva Secure EMA Validation for Lyme Vaccine
NEW YORK and LYON, France, August 14, 2026 Pfizer Inc. and Valneva SE announced that the European Medicines Agency...
Advertisements
Curium Acquires Abscint to Expand Oncology PET Pipeline
Boston, Mass. & Liège, Belgium, August 10, 2026 Curium announced the completion of its acquisition of Abscint SA, a...
Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103
Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...
Cytokinetics Wins UK Approval for MYQORZO in oHCM
SOUTH SAN FRANCISCO, Calif., July 30, 2026 Cytokinetics, Incorporated has achieved a major regulatory and market access milestone for...
Amgen’s Repatha Wins CHMP Support for Broader Heart Protection
THOUSAND OAKS, Calif., July 29, 2026 Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Atsena Therapeutics Secures EMA Orphan Status for Two Gene Therapies
DURHAM, N.C., July 23, 2026 Atsena Therapeutics announced that the European Medicines Agency (EMA) has granted Orphan Designation to...
Advertisement
